Unique Model of Dormant Infection for Tuberculosis Vaccine Development

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical and Vaccine Immunology

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CVI.00120-06PMID 16960113PMCID PMC1563568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates.

  2004cited by this paper
• A Two-Component Regulator of Universal Stress Protein Expression and Adaptation to Oxygen Starvation in Mycobacterium smegmatis

  2003cited by this paper
• Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence

  2002cited by this paper
• A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis

  2002cited by this paper
• An investigation of suspected exogenous reinfection in tuberculosis patients in Kampala, Uganda.

  2002cited by this paper
• Signalling: Initiation of pro-IL-1β processing

  2002cited by this paper
• Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge.

  2002cited by this paper
• T-Cell Responses to the Mycobacterium tuberculosis-Specific Antigen ESAT-6 in Brazilian Tuberculosis Patients

  2002cited by this paper
• Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.

  2001cited by this paper
• Microaerophilic Induction of the Alpha-Crystallin Chaperone Protein Homologue (hspX) mRNA ofMycobacterium tuberculosis

  2001cited by this paper
• Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10.

  2001cited by this paper
• Characterization of Auxotrophic Mutants ofMycobacterium tuberculosis and Their Potential as Vaccine Candidates

  2001cited by this paper
• Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin

  2001cited by this paper
• Molecular and Immunological Characterization ofMycobacterium tuberculosis CFP-10, an Immunodiagnostic Antigen Missing in Mycobacterium bovis BCG

  2000cited by this paper
• Attenuation of and Protection Induced by a Leucine Auxotroph of Mycobacterium tuberculosis

  2000cited by this paper
• Persistence and Protective Efficacy of aMycobacterium tuberculosis Auxotroph Vaccine

  1999cited by this paper
• Transcription of the Stationary-Phase-AssociatedhspX Gene of Mycobacterium tuberculosis Is Inversely Related to Synthesis of the 16-Kilodalton Protein

  1999cited by this paper
• Mycobacterial Stationary Phase Induced by Low Oxygen Tension: Cell Wall Thickening and Localization of the 16-Kilodalton α-Crystallin Homolog

  1998cited by this paper
• Human and Murine Immune Responses to a NovelLeishmania major Recombinant Protein Encoded by Members of a Multicopy Gene Family

  1998cited by this paper
• Effects of aminoguanidine on latent murine tuberculosis.

  1998cited by this paper
• Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis.

  1997cited by this paper
• Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog

  1996cited by this paper
• Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient.

  1995cited by this paper
• Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis

  1995cited by this paper
• Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.

  1995cited by this paper
• Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.

  1995cited by this paper
• Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

  1994cited by this paper
• Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity

  1993cited by this paper
• Immunization of mice with mycobacterial culture filtrate proteins

  1992cited by this paper
• Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

  1992cited by this paper
• An experimental model of chemotherapy on dormant tuberculous infection, with particular reference to rifampicin.

  1988cited by this paper
• A mouse model of the recrudescence of latent tuberculosis in the elderly.

  1988cited by this paper
• Recent advances in epidemiological research in tuberculosis.

  1982cited by this paper
• Distribution of mycobacteria grown in vivo in the organs of intravenously infected mice.

  1976cited by this paper
• Exogenous reinfection in tuberculosis.

  1970cited by this paper
• Experimental studies on host-parasite equilibrium in tuberculous infection, in relation to vaccination and chemotherapy.

  1966cited by this paper
• MICROBIAL PERSISTENCE

  1966cited by this paper
• MICROBIAL PERSISTENCE

  1966cited by this paper
• THE FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUE

  1956cited by this paper
• FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUE

  1956cited by this paper
• [Experimental studies on the mechanism of infection and immunity in tuberculosis from the analytical standpoint of streptomycin-dependent tubercle bacilli. 1. Isolation and biological characteristics of a streptomycin-dependent mutant, and effect of streptomycin administration on its pathogenicity i

  1955cited by this paper
• Pathogenetic concepts of tuberculosis.

  1950influential reference
• Native and acquired resistance to tuberculosis.

  1950cited by this paper

• Trends in Viral Vector-Based Vaccines for Tuberculosis: A Patent Review (2010–2023)

  2024cites this paper
• Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger

  2022cites this paper
• Mouse Models for Mycobacterium tuberculosis Pathogenesis: Show and Do Not Tell

  2022cites this paper
• Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells

  2021cites this paper
• Coronavirus Activates an Altruistic Stem Cell–Mediated Defense Mechanism that Reactivates Dormant Tuberculosis

  2021influential citation
• Corona virus activates a stem cell mediated defense mechanism that accelerates activation of dormant tuberculosis: implications for the COVID-19 pandemic

  2020cites this paper
• Stem cell basis of a host driven transmission of antigen packed aerosols: a novel mechanism of natural vaccination for tuberculosis

  2020influential citation
• Nitric oxide prevents a pathogen permissive granulocytic inflammation during tuberculosis

  2017cites this paper
• Mycobacterium tuberculosis strain 18b, a useful non-virulent streptomycin dependent mutant to study latent tuberculosis as well as for in vivo and in vitro testing of anti-tuberculosis drugs.

  2016cites this paper
• Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b

  2016cites this paper
• Investigation of mycobacterial survival in non-permissive growth conditions

  2015cites this paper
• CD271+ Bone Marrow Mesenchymal Stem Cells May Provide a Niche for Dormant Mycobacterium tuberculosis

  2013cites this paper
• Mycobacterium tuberculosis Dormant Bone Marrow Mesenchymal Stem Cells May Provide a Niche for + CD 271

  2013cites this paper
• Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β

  2012cites this paper
• Trafficking of Mycobacterium tuberculosis bacilli in type II pneumocytes

  2012cites this paper
• Current and novel approaches to vaccine development against tuberculosis

  2012cites this paper
• Mycobacterium marinum Causes a Latent Infection that Can Be Reactivated by Gamma Irradiation in Adult Zebrafish

  2012cites this paper
• Mycobacterium tuberculosis attenuated by multiple deletions of rpf genes effectively protects mice against TB infection.

  2011cites this paper
• Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis

  2010cites this paper
• Aspectos biológicos, clínicos y epidemiológicos de la tuberculosis latente

  2010cites this paper
• Cellular immunity of naïve and BCG vaccinated neonates

  2010cites this paper
• [Biological, clinical and epidemiological aspects of latent tuberculosis].

  2010cites this paper
• Experimental tuberculosis: designing a better model to test vaccines against tuberculosis.

  2010cites this paper
• Guinea Pig Model of Mycobacterium tuberculosis Dormant Infection

  2009cites this paper
• Mecanismos de evasión y persistencia de Mycobacterium tuberculosis durante el estado de latencia y posibles estrategias para el control de la infección latente

  2009cites this paper
• Reacciones adversas asociadas a la vacunación con bacilo de Calmette y Guérin en una población infantil de la ciudad de Zacatecas, México Adverse reactions in association with Bacillus Calmette-Guerin immunization in Mexican children

  2008cites this paper
• Guinea pig model of Mycobacterium tuberculosis latent/dormant infection.

  2008cites this paper
• Evaluation of novel vaccine candidates against tuberculosis in murine models of persistent and latent infection

  2008cites this paper
• Adverse reactions in association with Bacillus Calmette-Guerin immunization in Mexican children

  2008cites this paper